Zack Kubow | Investor Relations-Real Chemistry |
Leiv Lea | Chief Financial Officer |
Richard Miller | Co-Founder, President & Chief Executive Officer |
James Rosenbaum | Senior Vice President-Research |
Mara Goldstein | Mizuho |
Roger Song | Jefferies |
Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the Corvus Pharmaceuticals Fourth Quarter and Full Year 2022 Business Update and Financial Results Conference Call.
At this time, all participants will be in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time.
It is now my pleasure to turn the conference over to Zack Kubow of Real Chemistry.